dailysun.net.au

Modern Chinese Medicine Announces Year 2022 Interim Results; Expand distribution network to seize industry opportunities

  • Written by Daily Sun
PERFORMANCE HIGHLIGHTS

  • The Group posted a consolidated revenue of approximately RMB196.1 million for the six months ended 30 June 2022, representing an increase of approximately 14.1%
  • Gross profit increased by 9.9% to RMB86.4 million
  • Net profit increased by 13.1% to approximately RMB49.9 million
  • The increase in revenue was primarily driven by the surge in revenue generated from the sales of Vigour and Vitality Supplement Pill, Fever-removing and Detoxification Pill and Additional Ingredient Huoxiang Zheng Qi Pill
  • Northeast, the PRC remained as the largest contributor (55.7%) to the Group’s total revenue
  • The Group has currently established a distribution network for 83 distributors covering about 40 cities in the PRC

HONG KONG SAR - Media OutReach - 25 August 2022 - Modern Chinese Medicine Group Co.

More Articles ...

  1. Bybit Launchpad 2.0 to Host Token of Okse IEO
  2. Unlimint launches Banking as a Service API Solution
  3. Redress Design Award 2022 Finalists’ Photoshoot Honours Competition’s Legacy With A Warehouse Of Renewed Wear
  4. TECNO Mobile’s signature campaign ‘Stylish Affair’ for the launch of CAMON 19Pro 5G in India
  5. Introducing DuraTech™ by Microban®: a non-heavy metal antimicrobial cotton technology with superior wash durability
  6. MODIFI’s H2 2022 Predictions Report assesses current, forthcoming factors affecting global supply chains
  7. DHL Supply Chain celebrates the groundbreaking of DHL Yachiyo Logistics Center in Yachiyo, Chiba
  8. AAX Recognized by CoinGecko and CryptoCompare
  9. iZeno becomes the first APAC Partner to achieve Atlassian ITSM specialisation
  10. Aon Insights Series Asia 2022 to Explore Better Decision Making in an Increasingly Volatile Business World